Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2001
03/29/2001CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385851A1 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms
03/29/2001CA2385783A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1
03/29/2001CA2385697A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes
03/29/2001CA2385658A1 Hybridization self-recognition probe
03/29/2001CA2385552A1 Phosphatases which activate map kinase pathways
03/29/2001CA2385497A1 Methods and microorganisms for production of panto-compounds
03/29/2001CA2385496A1 Molecules for diagnostics and therapeutics
03/29/2001CA2385480A1 32 human secreted proteins
03/29/2001CA2385460A1 Rgs10b, a g-protein regulator expressed in osteoclasts
03/29/2001CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385425A1 Pcna associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385381A1 Susceptibility gene for inflammatory bowel disease
03/29/2001CA2385377A1 Method to identify compounds useful in the therapy of bone disorders
03/29/2001CA2385334A1 Novel syk kinase-associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385264A1 Method for determining the fertility of mammals, especially of humans
03/29/2001CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
03/29/2001CA2385235A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use
03/29/2001CA2385029A1 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
03/29/2001CA2384928A1 Method for identifying compounds useful in the therapy of bone disorders
03/29/2001CA2383629A1 Hybrid peptides modulate the immune response
03/29/2001CA2383591A1 Cell based assay
03/29/2001CA2383462A1 Therapeutic methods and compounds
03/29/2001CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
03/28/2001EP1087230A1 Method for identifying compounds useful in the therapy of bone disorders
03/28/2001EP1087020A2 Universal probes and methods for detection of nucleic acids
03/28/2001EP1087019A1 Method of detection of Mycobacteria
03/28/2001EP1087014A1 Hog cholera virus vaccine and diagnostic
03/28/2001EP1086494A1 Infrared thermography
03/28/2001EP1086378A1 Analytical method using multiple virus labelling
03/28/2001EP1086377A1 A method of identifying ligands to rna polymerase sigma 70 subunit
03/28/2001EP1086373A1 Cd7
03/28/2001EP1086250A2 Method of generating nucleic acid hybrids for mutation analysis
03/28/2001EP1086249A2 Diagnostic method based on quantification of extramitochondrial dna
03/28/2001EP1086248A1 Denaturing gradient affinity electrophoresis and methods of use thereof
03/28/2001EP1086247A2 Methods for the detection of nucleic acids
03/28/2001EP1086246A1 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
03/28/2001EP1086245A2 Multi-fluorescent hairpin energy transfer oligonucleotides
03/28/2001EP1086244A1 Restriction enzyme gene discovery method
03/28/2001EP1086243A1 Genotyping the human phenol sulfotransferase 2 gene (stp2)
03/28/2001EP1086242A1 Fluorescent assay for topoisomerase inhibitors
03/28/2001EP1086241A1 Non-viable cell preparation and assay reagent
03/28/2001EP1086240A1 Methods for testing biological network models
03/28/2001EP1086238A1 Human mp52 gene promoter and method for exploring useful substance by using the same
03/28/2001EP1086234A1 New human carboxypeptidase inhibitor
03/28/2001EP1086233A2 Cloning of human choline / ethanolaminephospho - transferases; synthesis of phosphatidyl - choline, phosphatidyle - thanolamine, and platelet activating factor
03/28/2001EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof
03/28/2001EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin
03/28/2001EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/28/2001EP1086222A2 Cell cycle regulation proteins
03/28/2001EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer
03/28/2001EP1086217A2 Novel angiotensin receptor, production and use thereof
03/28/2001EP1086216A2 Pseudo-cyclic oligonucleobases
03/28/2001EP1086213A2 Human genes differentially expressed in colon cancer
03/28/2001EP1086209A2 Fy7 polymerase
03/28/2001EP1086205A1 Methods of monitoring disease states and therapies using gene expression profiles
03/28/2001EP1086178A1 An anthraquinone and its derivatives
03/28/2001EP1086132A1 Gene encoding organic anion transporter
03/28/2001EP1086129A1 Anti-angiogenic proteins and methods of use thereof
03/28/2001EP1086125A1 Respiratory nitrate reductase alpha subunit
03/28/2001EP1086117A1 Cloning and identification of the motilin receptor
03/28/2001EP1086065A4 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086065A1 Combinatorial synthesis of multibinding libraries
03/28/2001EP1086064A2 Directed combinatorial compound library and high throughput assays for screening same
03/28/2001EP1086061A2 Malodorant compositions, related non-lethal weapon systems, and methods of their use
03/28/2001EP1085903A1 Egg surface proteins and methods for use for modulating fertility
03/28/2001EP1085899A1 Retinoic acid inducible dna sequences from lung cells
03/28/2001EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
03/28/2001EP1085893A1 Phosphodiesterase-v modulator drugs and their uses
03/28/2001EP1085891A1 Multibinding inhibitors of topoisomerase
03/28/2001EP1085861A1 Inhibitors of nitric oxide synthase
03/28/2001EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein
03/28/2001EP1085845A2 Multibinding inhibitors of cyclooxygenase-2
03/28/2001EP1045764A4 Labeling technique for countering product diversion and product counterfeiting
03/28/2001EP0863999B1 Method of detecting telomerase activity
03/28/2001EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
03/28/2001CN1289409A PAI-2 and t-PA as diagnostic markers of periodontal disease
03/28/2001CN1289374A Detection of wheat and barley fungal phthogens using the polymerase chain reaction
03/28/2001CN1289373A Inhibition of DNA modulation caused by mutated p53
03/28/2001CN1289372A Gene expression methods for screening compounds
03/28/2001CN1289369A Riboflavin biosynthesis genes from plants and uses thereof
03/28/2001CN1289367A Plant alkaline and neutral invertases
03/28/2001CN1289365A Inspection method for microorganisms and the like, and unit therefor
03/28/2001CN1288959A DNA footprint steeping drawing method
03/28/2001CN1288958A Non-istopic polymerase chain reaction as one method of single stranded conformational polymerphism detection of genic mutation
03/28/2001CN1288957A Application of rice leaf in polymerase chain reaction
03/28/2001CN1288956A Preservation method of mixed liquid of polymerase chair reaction
03/28/2001CN1288955A Multielement protein chip and its preparation and application
03/28/2001CN1063797C Electrophoresis system for analysis of short serial repeatitive sequence polymorphism in human genome
03/28/2001CA2283458A1 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis
03/27/2001US6208941 Method and apparatus for analysis of chromatographic migration patterns
03/27/2001US6207960 System and methods for detection of labeled materials
03/27/2001US6207880 Plants which synthesize a modified starch, process for the production thereof and modified starch
03/27/2001US6207820 Solid phase synthesis by linking acceptor monosaccharide to support forming carboxylate or carboxyamide linkage, covalently linking donor saccharide by o-glycosidic linkage, coupling lipophosphoglycerate mimetic, cleaving from support
03/27/2001US6207818 Amplification and detection of shigella spp. and enteroinvasive strains of Escherichia coli
03/27/2001US6207816 High affinity oligonucleotide ligands to growth factors
03/27/2001US6207811 Nephrin gene and protein
03/27/2001US6207810 TRT1 polynucleotides, host cells and assays
03/27/2001US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis
03/27/2001US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same